🇺🇸 FDA

Intelligence Platform

Patents

Browse 53 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8119590

Prevention and treatment of restenosis by local administration of drug

Esperion Therapeutics, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084498

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067466

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

Esperion Therapeutics, Inc. · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838554

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7812199

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709515

Compositions comprising ether compounds and pharmaceutical uses therefor

Esperion Therapeutics, Inc. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7705177

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576130

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335799

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7335689

Dihydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7192940

Ether compounds

Esperion Therapeutics, Inc. · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7119221

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6953840

Methods of using non-human animal Apolipoprotein A-I protein

Esperion Therapeutics, Inc. · Granted Tue Oct 11 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6909014

Intermediates for the synthesis of ether compounds

Esperion Therapeutics, Inc. · Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6831105

Compositions comprising ether compounds and pharmaceutical uses therefor

Esperion Therapeutics, Inc. · Granted Tue Dec 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790953

Ether compounds

Esperion Therapeutics, Inc. · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713507

Ether compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6703422

Sulfide and disulfide compounds and compositions for cholesterol management and related us

Esperion Therapeutics, Inc. · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6699910

Ketone compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673780

Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and rela

Esperion Therapeutics, Inc. · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6646170

Intermediates for the synthesis of ether compounds

Esperion Therapeutics, Inc. · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617134

Dimer of molecular variant of apolipoprotein and processes for the production thereof

Esperion Therapeutics, Inc. · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506879

Purified Apo A and Apo E compounds and methods for using them

Esperion Therapeutics, Inc. · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506799

Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hyperte

Esperion Therapeutics, Inc. · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired